Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
ENSG00000234175 is classified as a pseudogene on the Y chromosome with sequence similarity to parts of the chromodomain protein, Y chromosome, 1 (CDY1) gene[5]. Pseudogenes are genomic DNA sequences similar to normal genes but are generally nonfunctional due to mutations or lack of expression. As such, this entity does not encode a functional protein product, is not implicated as a receptor or enzymatic target, and has no known role in disease or therapeutic applications. Pseudogenes can sometimes be transcribed and may have minor regulatory or evolutionary significance, but there is no established evidence that this particular pseudogene plays such roles. It is not considered a druggable target or receptor in pharmacological or clinical contexts[4][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Pseudogene similar to part of chromodomain protein, Y chromosome, 1 (ENSG00000234175).